Sutherland's second messcn1-!cr model and the intraccllular cAMPt-system is presented. The key-points of its manipulation by externally applied compounds are discussed. They form the guidelincs for developmcnt of chemical analogues of thc cAMP molecule effective on phosphodiesterases and protein kinases.
THE SECOND MESSENGER MODEL
Tlie humoral regulation of various tissue functions in mammals depends on information transmitters, usually called 'hormones'. They are generated in secretory tissues, from which they are released as a response to neural or humoral stimuli. Thus, they transfer the information to the target organ. As an example, the regulation process in the thyroid system functions as follows : humoral and neural signals stimulate a primary endocrine gland (hypothalamus), the secreted hormone (TSH releasing factor) reaches via the circulation a dependent gland (pituitary gland), where the process is repeated. The secreted hormone (TSH) finally reaches the target organ (thyroid gland), exerts its influence on the tissue and is subsequently metabolized. This decrease in hormone concentration, in turn, may be a stimulus for renewed action of the primary endocrine gland.
Sutherland and his coworkers 1 t were the first to show that an intracellular increase of an adenosine nucleotide with a cyclic phosphate ester group (cAMP) precedes the hormone regulated events in the target tissues. Formation and degradation of cAMP is regulated by two ubiquitous enzymes (Figure 1 ), the ATP cyclase and the 3': 5'-phosphodiesterase (PDE). ATP cyclase forms an intramolecular ester-bond between the a:-phosphorus of ATP and the 3'-hydroxyl group, releasing inorganic pyrophosphate. The equilibrium of the reaction does _not favour cAMP formation. In some microorganisms the A TP cyclase is found in the cytoplasm, while the enzyme in cariontes occurs in membrane-bound form. When the enzyme is dissociated, for example by adding detergents, its capacity for activation by hormones is lost or drastically reduced. 
A-5'-MP
The intracellular cAMP-levels are strongly influenced by specific phosphodiesterases, which cleave the 3': 5'-cyclophosphate ring, forming the corresponding nucleoside-5' -monophosphate. The enzyme, isolated from various sources, is soluble and localized to a great part in the cytoplasm.
Since the discovery of Sutherland most hormones have been found to activate the ATP cyclase and thus elevate the intracellular cAMP-level (Table 1 ). The hormone-regulated A TP cyclase is the centrepiece of Sutherland's second messenger concept (review by Robison et al. 2 ;  Figure 2 ) and consequently, is the key to our current understanding ofhormone action. The particle-bound cyclase seems to be connected with a series of receptors, that differentiate between the various arriving hormones. One can assume, that the cell-surfaces of different tissues show different receptor patterns, and, therefore, they are stimulated by different hormones. Our present knowledge of the molecular mechanism of this hormone-induced activation 
~---------Feedback--------------------------~
Further target tissues Figure 2 . Second messenger model (modified according to Sutherland) . The primary response to a hormonal signal is the intracellular formation of cAMP which, in turn, produces typical effects. Compounds formed this way may act as hormonal signals in the extracellular space again .
• process is limited. Possibly prostaglandins are involved. The products resulting from the cellular response of the cAMP may influence both the secretory gland via a feedback mechanism, and a further target tissue, possibly by activating a cyclase again. In this chain of events the hormone is the first messenger and the cAMP the second.
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I t is surprising how many effects arise from the single event, cAMP elevation, such as changes in enzyme activity, in membrane potentials and in ion flux, until the effects of cAMP are neutralized by the specific PDE. A partial Iist of these actions is shown in Table 2 . In liver, glycogenolysis, gluconeogenesis, urea formation and inhibition of Iipid synthesis occurs, while in adipose tissue, lipolysis is stimulated. Generally speaking, in these tissues, stimulation of catabolic pathways prevails. The effects on contractile tissues as weil as on hormone release will be a further subject of this paper.
In cantrast to ATP, which represents the universal energy transmitter of the living cell, cAMP is, most likely, the universal intracellular information transmitter. The cAMP-concentration within the cell is about 10-7 M and is drastically lower than the concentration of other adenine nucleotides (e.g. ATP, ca. 10-3 M). cAMP apparently can cross the cell wall barrier from the intracellular to the extracellular space (but not in the reverse direction !), since cAMP is found in blood and in urine. THE cAMP-SYSTEM One is tempted to postulate that the multiplicity of biochemical events caused by the presence of cAMP is based on a common principle of action. Indeed, the discovery of cAMP-sensitive protein kinases in various tissues supports this assumption 3 • 4 . Protein kinases phosphorylate other catalytic proteins and thus modulate their activity. In general, protein kinases consist of regulatory and catalytic subunits. Binding of cAMP to the regulatory site causes the complex to dissociate, thereby releasing the enzymatically active, catalytic subunit of the protein kinase. The physiological substrates of the various protein kinases are not yet completely known. Their identification is necessary in order to clarify the mechanism of action of the second messenger in the different tissues.
Besides regulation ofvital cell processes by cAMP, there is good evidence that cGMP may play an important role, too (for a review, see Hardman et al. 5 ) . The tissue Ievel of cGMP is lower than that of cAMP by a factor of 10 to 100. The GTP cyclase which forms cGMP from GTP is partially soluble unlike the ATP cyclase. cGMP catabolism seems to be controlled by G-specific phosphodiesterases, though each nucleotide inhibits the other's hydrolysis. cGMP appears to stimulafe other protein kinases than cAMP. These facts imply that the spectrum of its biochemical effects is shifted, as compared to cAMP. The significance of the physiological occurrence of cGMP has not been ascertained so far.
The same holds true for various protein factors that seem to control the activity of phosphodiesterases and protein kinases 6 -8 . These more or less well established facts are compiled in Figure 3 . The chain of events is started by humoral or neural input signals. By elevation of the cAMP Ievel, enzyme activities are modulated either by direct effects or 
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via triggering the protein synthesis. These processes alter the dynamic situation of various metabolic pathways. Other tissue effects such as relaxation of the smooth muscle or increase of the force of contraction in the cardiac muscle are controlled by cAMP, at least partly by the regulation of the ion~transport, especially of the calcium flux. Both principles may be involved in the stimulation of hormone secretion by the second messenger. cAMP-effects depend primarily on the activities of ATP-cyclase, phosphodiesterase and protein kinase. Key positions for the modulations of the second messenger system are n um bered in Figure 3 . They are the A TP cyclase, consisting of the receptor site where the hormone signal is received (1), the phospholipid layer (2) , and the catalytic site at thc inner side of the plasma membrane (3), and further the phosphodiesterase (4), the regulatory site of the protein kinase (5) and subsequently its catalytic centre (6) after activation has taken place. In addition, indirect effects on the system may play an important role, e.g. phosphatases can dcactivatc phosphoproteins by dephosphorylation. Our present knowledge about the influence of cAMP-level on ion transport, especially on the calcium flux, is limited. Dotted lines in Figure 3 indicate this connection. Maybe this phenomenon reflects a feed-back mechanism, caused by ATPases. These membranebound A TP-hydrolyzing enzymes are presumably in close association with the ATP cyclase, both acting with ATP as the same substrate, however, with different affinity constants. Numbers 7, 8, 9 and 10 in Figure 3 show these more indirect points of attack.
Despite the fact that many details are still subject to speculation, the theoretical model explains the molecular mode of action of an ever increasing number of pharmaceutical and physiological agents. It may explain furthermore, why structurally widely different molecules may show the same or a very similar action in the same tissue. For example, lipolysis in fat pads is stimulated by cAMP. This system is blocked by a variety of compounds. The common basis for the antilipolytic effect is the decrease of cAMP Ievel. Figure 4 (redrawn from Butcher 9 ) shows this decrease of epinephrinestimulated cAMP Ievels by several antilipolytic compounds. Howcver, the point of attack for these agents is quite different. Insulin and propranolol act on different receptors of the adenyl cyclase system. Prostaglandins influence, very likely, the mechanism in the Iipid layer of the membrane. The effects of pyrazole derivatives and of nicotinic acidarenot yet completely understood. With insulin, a reaction with the cell surface is sufficient for a cellular response. This has been recently demonstrated by Cuatrecasas et al. 10 . Insulin, which had been fixed covalently on a macromolecular carrier (agarose), was fully active towards an adipose tissue culture. Inhibition of phosphodiesterases, causing elevation of the cAMP-level is at least partially responsible for the experimentally observed effects of other drugs as shown in Table 3 . The action of theophylline on the cardiac muscle, of papaverine on the smooth muscle, of phenothiazines on the central nervaus system and of sulphonylurea derivatives on the ß-cells of the pancreas are some examples of an involvement of PDE in drug action. A good indication is an increase in cAMP following drug administration. Thus it is not surprising that the comparison of the phosphodiesterase inhibition in special tissues with the physiological response in vivo plays an increasing role in drug development 11 - 13 .
cAMP-ANALOGDES
Drugs which show effects in the cAMP system should show principally multiple physiological responses. Since, however, those molecules frequently achieve high specificities, a tissue-specific distribution of enzymes of the cAMP-system must exist. These different enzyme patterns, on the other band, might offer a chance to achieve a selective mode of action by chemical modification of the native second messenger. Experiments along this line are being conducted in severallaboratories. Figure 5 shows the chemical alterations of the cAMP molecule, which have been reported so far. They include the C-2, C-6 and C-8 positions at the heterocyclic moiety, the N -glycosidic linkage, the substitution on the 2' -hydroxyl-site of the ribose and the Substitution of the oxygen in the P-0-linkages by -S-or ~--CH 2~. The ability of these derivatives to mirnie the various effects ofendogenaus cAMP was checked in in vitro and in vivo systems. lt could be demonstrated that chemical variation of the cAMP molecule produces remarkable changes in the biological activity profile. This line ofinvestigation originated from a derivative, N 6 ,2'-0-dibutyrylcAMP, which was developed by Posternak et al. 14 . Several authors have shown that the spectrum of effects of this derivative is similar to cAMP in most, but not in all systems, while the intrinsic activity-when measured in whole tissue preparations or in vivo---is much superior. It has been concluded that the increase in potency is due to the lipophilic character and, therefore, improved penetration properties. Moreover, this compound showed a much better resistance to enzymatic attack by phosphodiesterases. Later on it was shown, that increased activity was mainly due to the N 6 - monobutyryl residue, since the dibutyryl derivative loses its 2' -0-butyrylresidue under physiological conditions quite rapidly 15 . Measurement of sensitivity to PDE is of major importance in evaluating potential usefulness of cAMP-analogues. Table 4 shows the rate of hydrolysis of some cyclic nucleotides by phosphodiesterases, which were isolated from a variety of species and tissues. With the exception of cUMP, the cyclic pyrimidine nucleotides are not attacked. Recently a cUMP-specific phosphodiesterase was described, but its physiological significance is unknown so far 16 . Basedon currently available data, one may conclude that the enzymology of phosphodiesterase is very complex. This enzyme is not only found in the cytoplasm, but also in a particle bound form. Enzymes, derived from different species and from various tissues of the same species, apparently differ in many respects, Even from the same tissue, at least two forms can be identified, which differ in their molecular weight and the KA-values for cAMP and cGMP. The rate of hydrolysis of these two substrates is influenced by their concentration ratio 17 . In our laboratory, phosphodiesterase from bovine heart was investigated in more detail 18 . In the course of the purification of that enzyme, fractions with discernible activities towards cAMP and cGMP were isolated. In Table 5 , they have been named PDE-A and PDE-G. We checked the enzymatic activity in these fractions with a series of analogues. The rate of hydrolysis is given in per cent values relative to cAMP hydrolysis. When cAMP derivatives were tested, the relative rates of hydrolysis with both fractions were the same. When, however, the C-6 amino group on the nucleobase was replaced by a C-6 hydroxy group, that is, when derivatives of ciMP and cGMP were subjected to incubation with PDE-A and PDE-G, pronounced differences in the relative rates of hydrolysis were observed. As can be seen from Table 5 , the decisive factor whether a derivative behaves as an A-or as a G-type is apparently the substituent in the C-6 position of the molecule. Attachment of bulky substituents causes a decrease in the Table 5 . Splitting rates with two fractions of bovine heart PDE relative to the splitting rate of cAMP = 100 per cent 18 . Figures in parentheses represent the splittingrate relative to cGMP = 100 per cent. For more details see the text
Splitting rate with beef heart PDE, % hydrolysis rate. Summarizing our experiments with PDE, the susceptibility to enzymatic attack depends on the chemical structure as follows ( Figure 6 ). The highest resistance is observed with 8-substituted analogues, the corresponding C-6 and C-2 derivatives are less resistant 19 . The high biological stability of the s:substituted cyclophosphate analogues is at least partially 419 caused by the restricted rotation at the N -glycosidic linkage ( Figure 7) . The so-called syn-and anti-conformations differ in the relative position of purine base to the sugar moiety. It appears that the syn-form is more resistant to attack by PDE. In addition, the imidazole ring of the purine moiety seems to be a prerequisite for the binding to the activc site on the enzyme, in view of the resistance of pyrimidine nucleotides to enzymatic attack. Analogues modified at the C-6 and C-2 position arc not restricted in rotation around the N -glycosidic linkage and, therefore, are split by phosphodiesterase.
Syn Anti Figure 7 . Syn-and anti-forrns of cAMP. The conforrnations differ in the relative position of purine base to the sugar rnoiety. The syn-forrn seerns to be less attacked by PDE.
Kuo and Greengard 20 were the first to show that analogues of cAMP may act on protein kinases. Among other compounds, they tested the cyclic phosphate of tubercidine (an antibiotic, developed by the Upjohn Co., in which the N of position 7 is substituted by --CH=), and also the 5'-and the 3' -methylenephosphonate of cAMP, synthesized in the laboratories of the Syntex Co. including a cAMP-specific as well as a cG~1P-specific enzyme, both from Iobster muscle. The maximum of activity of these derivatives was found to be at about 10-6 M. Table 6 shows selected data from this paper. The tubercidine derivative stimulates all protein kinases in a similar way as cAMP depend. itself. The 5' -methylenephosphonate is active on the kinase from heart muscle, whereas the cGMP-specific enzyme from Iobster muscle is not affected. The cydic 3' -methylenephosphonate is not active in these systems. The effects of several 8-substituted cAMP derivatives on a protein kinase from bovine brain have been investigated in the Squibb Institute for Medical Research 21 • Very different effects have been found in this system, too. The data of Table 7 represent the extreme values. Whereas the 8-methylthiocAMP is even more effective than the second messenger, the 8 -ethanolamino-cAMP is not active. The different behaviour of cAMP analogues towards protein kinase from different tissues is the molecular basis for the effects in more complicated metabolic processes. In the following chapters, a brief discussion of the current knowledge of cAMP-function in the different systems, the effect of analogues on enzymes in cell-free systems, on isolated tissues and finally in vivo is presented. For simplification, statistical data shown in the original papers have been omitted.
GLYCOGENOLYSIS
The molecular mechanisms, by which the cAMP stimulates the transformation of liver and muscle glycogen into glucose are well known due to the work of Sutherland, Krebs and of Greengard ( Figure 9) . A cAMPdependent protein kinase activates by phosphorylation another kinase (phosphorylase kinase), which, in turn, converts the inactive phosphorylase-b into the active phosphorylase-a by phosphorylation with ATP. Simultaneously, the glycogen synthetase is inhibited by phosphorylation with the same protein kinase which initiates the glycogenolysis. The biological significance of this enzyme cascade lies in the extreme amplification of the hormonal input signal. The concentration of hormones in the blood stream is very small (about 10-11 M for peptide hormones, and somewhat higher for catecholamines). This signal of the first messenger is already amplified by Figure 9 . Cyclic AMP and glycogenolysis. The cAMP-dependent protein kinase activates by phosphorylation another kinase (phosphorylase kinase), which, in turn, convcrts the inactive phosphorylase into the active form. The glycogen synthetase is simultaneously inhibited by phosphorylation with the same protein kinase.
several orders of magnitude at the membrane. One can see therefore, how minimal amounts of a hormone may produce considerable conversion of metabolites. 
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In our laboratories, a large number of analogues were investigated with respect to glycogenolytic activity in supernatent from muscle or liver homogenate 22 • 23 (Figure 1 0) . Here we found a general stimulation of glycogenolysis, caused by very different concentrations. The dose responses vary by a factor of about 10 4 . In spite of this, all compounds display the same maximal activity. This structure-effect relationship is shown in Figure 11 . The question, whether analogues act via inhibition of phos- phodiesterase or via activation of protein kinase, may be answered by a comparison ofthe inhibitor constants of phosphodiesterase and the activation constants of glycogenolysis. As far as has been measured, the K 1 -values are two to three orders of magnitude greater than the KA -values, at least in the case of the 6-substituted analogues. Thus, the activation of glycogenolysis is determined by the protein kinase. These measurements were obtained in the liver system, but the data in skeletal muscle are almost identical. In the measurements made, the protein kinase was the rate limiting step. Contrary to the situation in other tissues, the protein kinases that activate glycogenolysis in liver and muscle appear to be similar. Different authors investigated the glycogenolytic and gluconeogenetic effects of cAMP and DBcAMP in the perfused liver of the rat and found very strong Stimulation, even in intact tissue. This was especially true, when the dibutyryl derivative was used 
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CYCLIC AMP ANALOGDES Paoletti et al. 27 have checked many analogues, prepared in our laboratories, for glycogenolytic effects in vivo. A selection of results is shown in Table 8 . The figures demonstrate an increase of blood sugar 30 minutes after i.p. administration of 20 and 80 mg kg-1 of the cyclic nucleotides. While the cell-free system represents thooctivity ofthe cyclic nucleotide per se, the in vivo system also depends on the penetration ability, the metabolic stability, the excretion pattern and, furthermore, on enzymatic Counterregulation. The activation constants of the in vivo system can be roughly estimated or extrapolated and may be correlated to the in vitro system. Here it can be shown that even with phosphodiesterase-resistant derivatives, a 1000-fold concentration of the in vivo experiments is required to obtain the same effects as those of the in vitro experiments. This difference appears to depend mainly on the penetration gradient 27 a. The spacing in Table 8 separate the various groups of analogues. The first group shows the dibutyryl derivatives as reference compounds. In the second group, the strong glycogenolytic activity of the N 6 -substituted cAMP-derivatives is striking. Interesting are the only slightly elevated values of the 8-bromo-derivatives and the Iack of blood sugar elevation by 2-substituted derivatives, as shown in the last group. Most ofthe compounds mentioned here are resistant towards hydrolysis with phosphodiesterase.
STEROIDOGENESIS
Trophic hormones of the anterior pituitary gland stimulate steroid synthesis in the adrenal cortexandin the gonads. This procedure is mediated by cAMP.It is likely that the cyclic nucleotide stimulates the oxidation ofthe cholesterol side chain, thus forming pregenolone as the common precursor of steroid hormones. The effect of the trophic hormones and of cAMP may be inhibited by puromycin, but not by actinomycin. Thus, the secretion of steroids is preceded by a protein synthesis, which apparently is horm?nally controlled at the translation step. In correlation with this, a cAMP-acttvated protein kinase, which phosphorylates ribosomal proteins selectiv_ely, was found in the adrenal cortex 28 effects of various concentrations of cyclic nucleotides on the binding of tritiated cAMP. As a reference, the counts resulting from 100 per cent binding of 3 H-cAMP are used. While (non-cyclic) AMP is almost without influence, the cyclic nucleotides of inosine and guanosine compete for the receptor site of the protein kinase, yet only with about 1 per cent of the effectiveness of cAMP.
The steroidogenic effects of these analogues have been compared with the acylated, lipophilic derivatives in slices of adrenal cortex tissue of the rat. DBcAMP was shown to be the most effective one, showing KA -values two orders of magnitude lower than the other derivatives 29 . cAMP and, even more, DBcAMP have been found to stimulate not only glucocorticoids but also aldosterone synthesis 30 • The KA-values were compared with ACTH (Table 9 ). cGMP and DBcGMP have been found to stimulate the synthesis of glucocorticoid~ at 10-3 M without any effect on aldosterone secretion. The activation of steroidogenesis in adrenal preparations by 8-substituted derivatives of cAMP was investigated in the Squibb 426 CYCLIC AMP ANALOGDES 31 . Some selected data are shown in Table 10 . The concentrations required for half-maximal secretion were compared. The 8-thiomethyl-cAMP has been shown tobe the most active derivative. Paoletti et a/. 27 measured the effects of a series of derivatives, synthesized in our laboratories, in rats in vivo. The increase of corticosterone 30 minutes after i.p. administration ofthe cyclic nucleotide is given in micrograms per ml (Table 11) . For comparison, ACTH shows a maximum increase of about 0.50 )lg ml-1 in this system. As before, the spacings separate the different groups of compounds. The first group shows butyryl derivatives of cAMP, cGMP and ciMP. Only at a high dose of 80 mg kg-1 does DBcAMP show a strong effect and butyryl-ciMP a moderate one. Very high activity is shown by the dimethoxyphenylethylamino-cAMP, which even induces steroidogenesis at 5 mg kg- 1 • Activity is also exhibited by 8-bromo-ciMP, a compound neither active in cardiovascular systems nor in glycogenolysis. Also of interest is the imidazol derivative, carboxyethyl-AICAR-cMP (bottom line ), which has a pronounced steroidogenic effect. As was shown in our laboratory, these AICAR-qerivatives. are strongly antilipolytic, too. This will be discussed in the following section.
LIPOLYSIS
The lipolysis of the adipose tissue is assumed to be a key process of metabolism in mammalian system, just as important as glycogenolysis. lt is stimulated by several hormones, triggering an enzyme cascade as shown in Figure 13 32 . The hydrolysis of the first fatty acid ester in the triglyceride has been demonstrated to be the rate limiting step. 1t is catalyzed by a hormone-sensitive triglyceride Iipase. In· the laboratories of Krebs and Steinberg, the activation of this Iipase by cAMP-dependent protein kinase was found 32 • 33 . The understanding of the whole system is complicated by a sensitivity to several hormones, by the cooperation of several lipases and probably by a hormone antagonist, arising in the course of lipolysis 3 4 (for a review see Ref. 9).
CYCLIC AMP ANALOGDES
Blecher and coworkers 35 compared the lipolytic activity of several cyclic nucleotides in permeable adipocytes of the epididymal fat pad of the rat. This. is shown in Figure 14 . lt is somewhat surprising that, in this system, without the barrier of a plasma membrane, the DBcAMP was found to be the most active derivative. The saturation curves prove, nevertheless, the lipolytic activity of most of the other derivatives, with the single exception of cdTMP. Lipolytic activity was also shown by the cTuMP 36 . The effects of several 6-, 8-and 2' -substituted derivatives have been investigated bothin the Squibb Institute for Medical Research 31 andin our laboratories. The 8-thiomethyl-cAMP, the 8-benzylamino-cAMP and the 8-benzylamino-clMP have been found to be the most active lipolytic derivatives in the permeable adipocyte system. The effect of the DBcAMP was not surpassed in any case.
An interesting behaviour in the lipolytic system has been found with ribotides of the 5-amino-imidazole-4-carboxamide (AICAR). Its cyclic phosphate and, cven more, its 5' -monophosphate have a strong antilipolytic activity, bothin the cell-free systemandin the isolated adipocyte, as shown in Figure 15 . This is contrary to the effects ofmost ofthe other cyclic nucleotides. AICAR itself is without any effect in this system 37 . There are, nevertheless, derivatives of adenosine, which are strongly antilipolytic, e.g. the N 6 -isopropyl-ASN (PIA), studied by Dietmann et al.
•
1t acts very likely via an inhibition ofthe cyclase, as was shown by Westermann et al. 39 . In Figure 16 9 is shown the dramatic decrease of the intracellular cA MP·level after treatment of rat adipocytes with PIA, the lipolysis being prestimulated by hormones. AICAR-derivatives seem to affect (at least partially) the protein kinase -3% Figure 15 . Antilipolytic effects of AICAR-derativcs in adipocytes and in the cell-free systems from fat-pads of the rat (selected data from Michal et al.
).
It is noteworthy, that neither cAMP nor most of its derivatives which have been measured so far, showed any lipolytic activity in vivo. On the contrary, there was a slight antilipolytic response ofDBcAMP 40 . The reason for this may be a counter-regulation, but nevertheless, its mechanism is not yet understood. 
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CYCLIC AMP ANALOGUES SECRETION OF PITUITARY HORMONES The secretion of the hormones of the pituitary gland is probably regulated by factors released from the hypothalamus. Releasing factors for pituitary hormones have been purified from hypothalamus extracts. They enter the pituitary gland via a portal system and activate cyclases in specific areas of the anterior lobe. As was shown by Labrie et a/.
4 \ cAMP stimulates the hormone secretion as well as the protein synthesis in pituitary tissue.
The substrates of a cAMP-dependent protein kinase (purified from pituitary anterior lobe) were found in the rough microsomes, in the secretory granulcs andin the plasma membrane. These effects are summarized in the scheme proposed by Labrie et a/. 41 ( Figure 17 ). 
CYCLIC AMP ANALOGUES
Another interesting derivative which was synthesized and investigated by the same authors was the iso-cAMP, shown in Figure 19 (Cehovic 44 ) .
Here, the ribotide moiety is shifted from the imidazole to the pyrimidine moiety of the purine molecule. Whereas this compound strongly stimulates the secretion ofTSH, it is much less effective in stimulating growth hormone release 43 .
EFFECTS OF cAMP-ANALOGUES ON CONTRACTILE TISSUES
Thc involvement of cAMP in the contraction of vascular smooth muscle ofthe trachea, ileum, and uterus, has been thoroughly investigated. Although the mechanism is not yet fully understood, the vasoconstrictive response on CY-adrenergic stimulation is assumed to be related to a decrease, the vasodilatory response on ß-adrenergic stimulation to an increase of the intracellular cAMP level 45 . Because ofthelarge differences ofthe relative activities of cyclase and phosphodiesterase between the centre and the periphery of the vascular system and because of the different response of the cAMP-system in the various layers of the vascular wall, it is difficult to give a unifying interpretation of drug effects on this system 46 . The perfused, isolated artery of the rat responds to a periarterial electrical stimulation (e.g. catecholamine release) with contractions. The same effect is achieved by drugs, stimulating the vascular tone (ergotamine, imidazole). In this system Berti et al. 4 7 showed a strong relaxation after DBcAMP, whereas cAMP itself has a small, but ·significant contractive effect. As is shown in Figure 20 , the 8-bromo-cGMP has a strong relaxing effect on caudal artery which antagonizes both the electrical stimulation and the basal tone 
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The GTP-cyclase is most active in the lung (rats), where the activity is tenfold high er than in other tissues 49 • 50 . There may be a special function of cGMP in lung tissue, probably connected to the phosphodiesterase system. This. was shown by several authors 51 • 52 . Szaduykis-Szadurski et al. 53 investigated the effect of several analogues of cAMP and cGMP on the smooth muscle of the isolated trachea of guinea pig. In this system too, 8-bromo-cGMP was the most active derivative. A comparison of the effects of8-bromo-cGMP, DBcAMP and DBcGMP is shown in Figure 21 from Szaduykis-Szadurski and Berti
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). The upper left graph shows the dose-dependent smooth muscle relaxing efTect of8-bromo-cGMP. The upper right graph demonstrates the effect on imidazole-contracted muscle, which is antagonized by the cGMP derivative. The lower graph shows the corresponding effects of the dibutyryl derivatives, which antagonize imidazole only at 20-fold to 80-fold higher concentrations than 8-bromo-cGMP. Berti 54 demonstrated in in vivo-experiments that 8-bromo-cGMP relaxed histamine-induced bronchospasms in the guinea pig twice as effectively as theophylline. It should be emphasized that neither 8-bromo-GMP nor 8-bromo-guanosine showed any effect in either of these systems.
At the Squibb Institute for Medical Research, several 8-substituted cAMP-derivatives were compared with theophylline in a similar tracheal system 55 . Selected data are shown in Table 12 . The most effective compound was 8-benzylthio-cAMP, being almost 10 times more active than DBcAMP. The 8-bromo-cAMP was almost as active as DBcAMP. Similar data were obtained with the portal vein of the rat. None of these derivatives, however, reached the response of theophylline (which was surpassed, as shown above, by 8-bromo-cGMP). This compound, therefore, reveals a pronounced relaxing activity on the vascular smooth muscle. Finally, let us consider the cardiovascular response. The effects of epinephrine and glucagon (the positive inotropic effect on heart muscle and coronary vasodilatation) are accompanied by an elevation of the cAMP level, although the exact mechanism is still under discussion. The response in muscle seems tobe closely connected with the mobilization of intracellular pools of calcium. A further system of cyclases, bound to subcellular particles, Table 13 . Effect of analogues of cAMP on blood pressure and heart rate (anaesthetised rats, 20 mg kg-1 , i.v.). (Selected data from Paoletti et al.
)
Compound Blood pressure (mmHg) Heart rate (min-is induded ip the discussion of the mechanism as well as the effect of another second messenger. In view of this not yet well understood mechanism of contractile response to cAMP, the measurements of blood pressure and heart rate should be und.erstood phenomenologically only. Table 13 shows the results obtained with anaesthetised rats 27 . O~e may correlate the data with those of DBcAMP and DBcGMP, shown in the first group. There is a strong response to compounds with an aralkylgroup in the N 6 -position, such as N 6 -dimethoxyphenylethyl-cAMP. Similar substituents in the 8-position of cAMP (third group) have no efft:ct. As mentioned above, some of these 8-substituted derivatives (e.g. 8-methylmercapto-and 8-benzylamino-cAl\1P) have strong metabolic effects in other tissues. Substituents attached to the ciMP or cGMP moieties at the 8-and 2-positions d.o not cause effects on blood pressure and heart rate, although some of these compounds have steroidogenic effects, while the 8-bromocGMP relaxes the vascular smooth muscle, as was shown before.
PHARMACOLOGICAL ASPECTS
Do those find.ings have any significance for the development of new drugs? Considering the different patterns of the physiological response and the rather high specificity ofthe effects seen with some ofthese cAl\1P-derivatives, one may be optimistic. As we have seen, this specificity distinguishes steroidogenesis, antilipolysis, hormone secretion, the relaxation of vascular smooth muscle, etc. lt. seems possible to obtain compounds exerting metabolic effects qUite free from vasodilatory action. Also, compounds showing effects on the tracheal smooth muscle without affecting the card.iovascular system can be selected. Finally, we have seen that the multivalent response of the second messenger--without higher specificity---is much enhanced in Söme analogues, e.g. DBcAMP.
As was found by Levine et al., some of the effects of DBcAl\1P can also be reproduced in humans. The chance of such a multivalent derivative being used as a therapeutic agent depends on whether one can demoostrate that a pathological deficiency is due to a disturbance of the first messenger system. Since our knowledge of pathogenesis is not developed so far, it is too early to prove this point. Compounds with more specific effects appear easier to put to work. Moreover, for the time being, second messenger analogues seem to be a useful tool in the elucidation of basic biochemical mechanisms. This may Iead. to a better understanding of molecular events in drug effects. In the future, we hope that medicine, as well as biochemistry, will be able to describe normal and pafhological behaviour of cellular systems in the common language of molecular biology.
